Both Intestinal and Hepatic Lipoprotein Production Are Stimulated by an Acute Elevation of Plasma Free Fatty Acids in Humans

• DOI: 10.1161/circulationaha.107.739888
• Publication Date: 2008-04-29T01:24:40Z
• Authors: Hélène Duez; Benoît Lamarche; René Valéro; Mirjana Pavlic; Spencer Proctor; Changting Xiao; Linda Szeto; Bruce W. Patterson; Gary F. Lewis
• Keywords: Adult; Male; 0301 basic medicine; Time Factors; Metabolic Clearance Rate; Lipoproteins; Fatty Acids, Nonesterified; Middle Aged; Lipids; Intestines; 03 medical and health sciences; Liver; Humans; Intestinal Mucosa; Apolipoprotein B-48; Infusions, Intravenous

Background—

Hepatic lipoprotein production has been shown previously to be regulated by free fatty acid (FFA) flux to the liver, whereas intestinal lipoprotein production is stimulated mainly by ingested fat absorbed from the intestinal lumen. Emerging evidence indicates that intestinal lipoprotein production is increased in insulin resistance and type 2 diabetes mellitus, conditions that are associated with increased levels of circulating FFAs. Here we investigated whether short-term elevation of plasma FFAs stimulates intestinal apolipoprotein (apo) B-48– and hepatic apoB-100–containing triglyceride-rich lipoprotein (TRL) production in humans in the fed state.

Methods and Results—

TRL apoB-48 and apoB-100 metabolism were examined in 12 healthy men during a constant fed state. The studies were as follows, respectively: (1) Intralipid/heparin was infused intravenously immediately before and during the kinetics study to induce an ≈3-fold difference in plasma FFA compared with the saline study; (2) saline was infused intravenously as a control. ApoB-48– and apoB-100–containing TRL production and clearance were determined with a 12-hour primed constant infusion of [D3] l -leucine and multicompartmental kinetic modeling. TRL apoB-48 production rate was 69% higher in the Intralipid/heparin study than in the saline control (5.95±1.13 versus 3.53±0.58 mg/kg per day; P =0.027), and there was no significant difference in TRL apoB-48 clearance. TRL apoB-100 concentrations were also increased ( P <0.001) and TRL apoB-100 production rate was 35% higher in the Intralipid/heparin study compared with saline (28±4 versus 21±3 mg/kg per day; P =0.020).

Conclusions—

This is the first study to demonstrate that intestinal TRL apoB-48 production is increased after short-term elevation of plasma FFAs in humans in the fed state, similar to the well-described stimulation of hepatic TRL apoB100–containing particles by FFAs.